Micardis, Telmisartan Wire
Comprehensive News Feed for Micardis, Telmisartan (generic).
Results 1 - 20 of 142 in Micardis, Telmisartan (generic)
-
Is an ACE/ARB combo better than either drug alone?
ADDRESS: Franz H. Messerli, MD, Division of Cardiology, St. Luke's Roosevelt Hospital Center, 1000 10th Avenue, Suite 3B-30, New York, NY 10019; e-mail FMesserli{at}aol.com . MELANA YUZEFPOLSKAYA , MD A: No. Comment?
-
Major European Regulatory Milestone In Cardiovascular Protection For MICARDIS
Main Category: Cardiovascular / Cardiology Also Included In: Regulatory Affairs / Drug Approvals ; Heart Disease Article Date: 30 Nov 2009 - 0:00 PST Boehringer Ingelheim announced that the European Commission has approved MICARDIS for the reduction of cardiovascular morbidity in patients with: I. manifest atherothrombotic cardiovascular disease ... Comment?
-
Health Canada Approves New Treatment Option For Canadians At High Risk Of Heart Attack Or Stroke
Main Category: Heart Disease Also Included In: Stroke Article Date: 28 Nov 2009 - 0:00 PST MICARDIS has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme ... Comment?
-
Major European Regulatory Milestone in Cardiovascular Protection for...
Closely following FDA approval, MICARDISA is now indicated by the European Commission for the reduction of CV morbidity in patients with manifest atherothrombotic CV disease or type 2 diabetes with documented target organ damage. Comment?
-
Public relations, press release distribution, investor relations, SEC filing
The Finalists in the six judged... e ae -- DUBLIN-- --Research and Markets has announced the addition of the "Consumer Data Propositions" report to their offe... Comment?
-
European Commission approves MICARDIS medication for CV protection
Boehringer Ingelheim announced today that the European Commission has approved MICARDISA for the reduction of cardiovascular morbidity in patients with: I. manifest atherothrombotic cardiovascular disease or, II. Comment?
-
New treatment option will reduce cardiovascular risk for the up-to-44 per cent of patients who cannot tolerate ACE inhibitors MICARDIS has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate ... Comment?
-
Health Canada OKs new indication for Boehringer Ingelheim's MICARDIS
High risk of cardiovascular events includes evidence of coronary artery disease, peripheral arterial disease, stroke, transient ischemic attack, or diabetes mellitus with evidence of end-organ damage. Comment?
-
Health Canada approves MICARDIS(R) (telmisartan) as the first...
Health Canada approves MICARDIS as the first treatment in its class to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme inhibitor New treatment option will reduce cardiovascular risk for ... 1 comment
-
Vigorous Exercise Cuts Stroke Risk for Men, Not Women
w/Photo
Moderate-to-high intensity exercise such as jogging, swimming or tennis may help reduce stroke risk in older men but not in women, researchers report. Comment?
-
Sleep Disorders Plague Cancer Patients
w/Photo
Insomnia and sleep disorders affect more than three-quarters of cancer patients undergoing chemotherapy, a rate nearly three times higher than that of the general population, a new study finds. Comment?
-
Missing Gene Tied to Bone Marrow Transplant Problems
w/Photo
Researchers are reporting that a genetic variation -- a missing gene -- boosts the risk that someone who's had a bone-marrow transplant will develop a complication called graft-versus-host disease. Comment?
-
Stunts Raise Injury Risks for Cheerleaders
w/Photo
Anyone who has witnessed a modern cheerleading competition will not be surprised to learn that a new study has found that stunts cause 60 percent of cheerleading injuries in the United States. Comment?
-
When Sleep Suffers, So Does Decisiveness
w/Photo
Sleep-deprived people may put themselves and others at risk when they need to make split-second decisions, U.S. researchers have found. Comment?
-
Telmisartan-Induced Inhibition of Vascular Cell Proliferation Beyond...
Hypertension. 2009;54:1353-1359 Published online before print October 12, 2009, doi: 10.1161/HYPERTENSIONAHA.109.138750 Original Articles Telmisartan-Induced Inhibition of Vascular Cell Proliferation Beyond Angiotensin Receptor Blockade and Peroxisome Proliferator-Activated Receptor- Activation Koichi Yamamoto ; Mitsuru Ohishi ; Christopher Ho ; ... Comment?
-
Pfizer Inc Submits New Pediatric Data for Lipitor to EMEA
From EquityBites Health care company Pfizer Inc declared on Wednesday the submission of paediatric data for Lipitor to the European Medicines Agency . Comment?
-
Elderly Treated Less Aggressively for Heart Attack
w/Photo
While overall care of heart attack patients in the United States is good, gaps remain in the treatment of patients 80 and older, a new study suggests. Comment?
-
The Case for Dual Renin-Angiotensin System Inhibition [Editor's Correspondence]
Ku et al1 cite the findings of the Renal Outcomes With Telmisartan, Ramipril, or Both, in People at High Vascular Risk trial2 in arguing against dual renin-angiotensin system inhibition in chronic kidney disease. Comment?
-
Health Tip: Follow Directions When Taking Medication
Renal Failure November 2, 2009 FDA notified healthcare professionals of revisions to the prescribing information for Byetta to include... More... Latest Drug Information Updates Cervarix Cervarix is a is a preventative cervical cancer vaccine for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human ... Comment?
-
Health Tip: Triggering Abdominal Bloating
Renal Failure November 2, 2009 FDA notified healthcare professionals of revisions to the prescribing information for Byetta to include... Accusure Insulin Syringes - Recall October 27, 2009 Qualitest Pharmaceuticals and FDA notified healthcare professionals of a nationwide recall of Accusure Insulin Syringes. Comment?
Micardis, Telmisartan Forum
Most Popular
- Palin Left Hawaii Because Of Too Many Asians: Father - 561 comments
- Judge: Parents bigots for opposing immoral lessons - 684 comments
- Obama Says He Concentrating on Jobs - 135 comments
- Michelle Obama Wore Clothes to Light the Christmas Tree - 143 comments
- Gays 'will never go to heaven': cardinal - 159 comments
- Farrakhan: America's time is up - 104 comments
- Transgender teen: McDonald's refused to hire me - 199 comments
- Courts to Hear Appeal of Christians Who Want to Exclude Gays - 85 comments
- Reality TV Contestants Slammed For Cooking Rat - 65 comments
- Report Says Tiger's Wife Has moved Out of House & Mistress Count Up to 9 - 76 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
